David A. Whipple

Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor

Paul S. Changelian, Mark E. Flanagan, Douglas J. Ball et al. · Science · 2003 · 670 citations · Full text

Medicine, Immunology, Pharmacology +17

Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection

Mark E. Flanagan, Todd A. Blumenkopf, William H. Brissette et al. · Journal of Medicinal Chemistry · 2010 · 335 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Construction of a hybrid quadrupole/fourier transform ion cyclotron resonance mass spectrometer for versatile MS/MS above 10 kDa

Steven M. Patrie, Jay P. Charlebois, David A. Whipple et al. · Journal of the American Society for Mass Spectrometry · 2004 · 113 citations

Pharmacy, Biochemistry, Microbiology +14

Application of Genetic Algorithms to Combinatorial Synthesis:  A Computational Approach to Lead Identification and Lead Optimization^,

Jasbir Singh, Mark A. Ator, Edward P. Jaeger et al. · Journal of the American Chemical Society · 1996 · 111 citations

Pharmacy, Biotechnology, Molecular Biology +17

The specificity of JAK3 kinase inhibitors

Paul S. Changelian, Deborah Moshinsky, Cyrille Kuhn et al. · Blood · 2007 · 95 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +11